Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
BJU International|June 3, 2015
Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapiesAshish M Kamat, Daniel L Willis, Rian J Dickstein, et al.
The Journal of Urology|January 17, 2012
Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trialAshish M Kamat, Rian J Dickstein, Fabrizio Messetti, et al.
The Journal of Urology|September 26, 2014
Clinical outcomes of cT1 micropapillary bladder cancerDaniel L Willis, Mario I Fernandez, Rian J Dickstein, et al.
The Journal of Urology|August 6, 2013
Refining patient selection for neoadjuvant chemotherapy before radical cystectomyStephen H Culp, Rian J Dickstein, H Barton Grossman, et al.
The Journal of Urology|April 7, 2023
Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 StudyMark D Tyson, David Morris, Juan Palou, et al.
BJU International|October 19, 2016
Clinical risk stratification in patients with surgically resectable micropapillary bladder cancerMario I Fernández, Stephen B Williams, Daniel L Willis, et al.
Urologic Oncology|July 30, 2023
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumorsJoseph M Jacob, Solomon L Woldu, Jennifer Linehan, et al.
Pageof 2